Marshwinds Advisory Co Lowers stake in Chemours Co (CC)

Chemours Co (CC) : Marshwinds Advisory Co reduced its stake in Chemours Co by 0.82% during the most recent quarter end. The investment management company now holds a total of 179,182 shares of Chemours Co which is valued at $2,664,436 after selling 1,483 shares in Chemours Co , the firm said in a disclosure report filed with the SEC on Oct 13, 2016.Chemours Co makes up approximately 1.33% of Marshwinds Advisory Co’s portfolio.

Other Hedge Funds, Including , First Premier Bank boosted its stake in CC in the latest quarter, The investment management firm added 138 additional shares and now holds a total of 914 shares of Chemours Co which is valued at $13,591. Chemours Co makes up approx 0.01% of First Premier Bank’s portfolio.North Star Investment Management Corp. reduced its stake in CC by selling 234 shares or 24.27% in the most recent quarter. The Hedge Fund company now holds 730 shares of CC which is valued at $10,994. Raymond James Trust N.a. sold out all of its stake in CC during the most recent quarter. The investment firm sold 11,181 shares of CC which is valued $173,417. Simplex Trading sold out all of its stake in CC during the most recent quarter. The investment firm sold 14,791 shares of CC which is valued $232,958.

Chemours Co closed down -0.45 points or -2.90% at $15.06 with 16,83,407 shares getting traded on Tuesday. Post opening the session at $15.38, the shares hit an intraday low of $14.809 and an intraday high of $15.41 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, Chemours Co reported $0.27 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Aug 8, 2016. Analyst had a consensus of $0.17. The company had revenue of $1383.00 million for the quarter, compared to analysts expectations of $1418.96 million. The company’s revenue was down -8.3 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $-0.10 EPS.

The Chemours Company (Chemours) is a provider of performance chemicals. The Company delivers solutions with a range of industrial and specialty chemical products for markets including plastics and coatings refrigeration and air conditioning general industrial and mining and oil refining. The Company operates through three segments: Titanium Technologies Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2) under the brands including Ti-Pure and Vantage. Its Fluoroproducts segment is a provider of fluoroproducts under the brands including Suva ISCEON Freon Opteon Teflon Tefzel Viton Krytox Formacel Dymel FM 200 Nafion and Capstone. Its Chemical Solutions segment is a provider of industrial and specialty performance chemicals under the brands including Virkon and Oxone. The Company’s products include titanium dioxide refrigerants industrial fluoropolymer resins sodium cyanide sulfuric acid and aniline.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Chemours Co - Is it time to Sell?

Top Brokerage Firms are advising their investors on Chemours Co. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.